Role of beta-3-adrenoceptor in catecholamine-induced relaxations in gastric fundus from control and diabetic rats

Pharmacology

Volumn 80, Issue 4, 2007, Pages 227-238

  Ozakca, Isil ^a   Arioglu, Ebru ^a   Guner, Sahika ^a   Altan, V Melih ^a   Ozcelikay, A Tanju ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Beta 3 adrenoceptor; Beta adrenoceptors; Diabetes; mRNA; Rat gastric fundus; Streptozotocin

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CATECHOLAMINE; ISOPRENALINE; MESSENGER RNA; METOPROLOL; NADOLOL; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESPONSE; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA TRANSCRIPTION; SMOOTH MUSCLE RELAXATION; STOMACH FUNDUS; STOMACH MUSCLE; STREPTOZOCIN DIABETES;

ANIMALS; CATECHOLAMINES; DIABETES MELLITUS, EXPERIMENTAL; ETHANOLAMINES; FENOTEROL; GASTRIC FUNDUS; ISOPROTERENOL; MALE; MUSCLE RELAXATION; NOREPINEPHRINE; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-3; RNA, MESSENGER; STREPTOZOCIN;

EID: 35048848571     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104876     Document Type: Article

References (31)

1. Lafontan M, Berlan M: Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993;34:1057-1091.
2. Martin CAE, Advenier C: Beta-3-adrenoceptors and airways. Fundam Clin Pharmacol 1995;9:114-118.
3. Trochu JN, Leblais V, Rautureau Y, Beverelli F, Le Marec H, Berdeaux A, Gauthier C: Beta-3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol 1999;128:69-76.
4. 3-adrenoceptor in the human heart. J Clin Invest 1996;98:556-562.
5. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG: Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967;214:597-598.
6. Arch JRS, Kaumann AJ: Beta-3 and atypical beta-adrenoceptors. Med Res Rev 1993;13:663-729.
7. 2-subtype. Br J Pharmacol 1993;110:442-446.
8. 3-adrenoceptor antagonist bupranolol. Pharmacology 1999;59:290-297.
9. 3- adrenoceptors in rat ileum. Br J Pharmacol 1999;127:949-961.
10. Horinouchi T, Koike K: Characterization of atypical β-adrenoceptors in the guinea pig duodenum. Eur J Pharmacol 1999;376:61-66.
11. MacDonald A, Watt K: Characterization of the atypical β-adrenoceptor in rabbit isolated jejunum using BRL37344, cyanopindolol and SR59230A. J Auton Pharmacol 1999;19:91-95.
12. 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro. Br J Pharmacol 1990;101:569-574.
13. 3-adrenoceptor in the rat. Br J Pharmacol 1996;118:2085-2098.
14. McLaughlin DP, MacDonald A: Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical β-adrenoceptor. Br J Pharmacol 1991;103:1351-1356.
15. 3-receptor? J Pharmacol Exp Ther 1995;272:446-451.
16. Koch KL: Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus. A review of symptoms, pathophysiology, and treatment. Dig Dis Sci 1999;44:1061-1075.
17. Ozturk Y, Altan VM, Yildizoglu-Ari N: Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 1996;48:69-112.
18. Sakai Y, Inazu M, Aihara K, Inoue K, Homma I: Relations between contractile responses and β-adrenoceptors in gastric fundus of diabetic rats. Life Sci 1991;48:1043-1049.
19. Altan VM, Yildizoglu-Ari N, Ozturk Y: Decreased gastrointestinal responses to certain agonists in streptozotocin- and alloxan-diabetic rats in vitro. Pharmacology 1987;34:143-148.
20. Vane JR: A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother 1957;12:344-349.
21. Arunlakshana O, Schild HO: Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 1959;14:48-58.
22. 1-adrenergic receptor. Am J Physiol 2001;280:E199-E202.
23. Wilson C, Wilson S, Piercy V, Sennit MV, Arch JRS: The rat lipolytic β-adrenoceptor: studies using novel β-adrenoceptor agonists. Eur J Pharmacol 1984;100:309-319.
24. Horinouchi T, Yamamoto Y, Koike K: Effect of SR59230A on atypical β-adrenoceptor mediating relaxation in the guinea-pig gastric fundus. Pharmacology 2001;62:98-102.
25. Blue DR, Bond RA, Adham N, Delmondo R, Michel A, Eglen RM, Whiting RL, Clarke DE: Interaction of dihydroalprenolol and cyanopindolol with atypical β-adrenoceptors in guinea-pig ileum. Br J Pharmacol 1989;96:242P.
26. 3-adrenoceptors in the guinea pig gastric fundus. J Smooth Muscle Res 2001;37:105-112.
27. 3-adrenoceptors in rat isolated ileum. Br J Pharmacol 1993;110:1375-1380.
28. Kubota Y, Nakahara T, Yunoki M, Mitani A, Maruko T, Sakamoto K, Ishii K: Inhibitory mechanism of BRL37344 on muscarinic receptor-mediated contractions of the rat urinary bladder smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 2002;366:198-203.
29. 4- adrenoceptors in the guinea pig gastric fundus: stereoselectivity, β-adrenoceptor alkylation, and structure-activity relationship. Can J Physiol Pharmacol 2001;79:985-995.
30. Abell TL, Camilleri M, Hench VS, Malagelada JR: Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol 1991;3:163-167.
31. Undeland KA, Hausken T, Sveak S, Aanderud S, Berstad A: Wide gastric antrum and low vagal tone in patients with diabetes mellitus type I compared to patients with functional dyspepsia and healthy individuals. Dig Dis Sci 1996;41:9-16.